Global Digital Respiratory Devices Market

2.1    Impact Analysis
2.2    Market Drivers
         2.2.1    Increasing Prevalence of Respiratory Diseases
         2.2.2    Increasing Adoption of Digital Technology Among Individuals
         2.2.3    Treatment Satisfaction with Inhaled Therapy Among Individuals
2.3    Market Restraints
         2.3.1    Issues Related to The Accuracy and Reliability of the Device
         2.3.2    Availability and High Cost Associated with Digital Respiratory Devices
2.4    Market Opportunities
         2.4.1    Expansion into the Emerging Markets
         2.4.2    Predicting Future Exacerbations

3.1    Impact on Market Size
         3.1.1    Scenario Comparative Analysis (Pre-COVID-19, During-COVID-19, Post-COVID-19)
         3.1.2    Regional Impact
                     3.1.2.1    North America
                     3.1.2.2    Europe
                     3.1.2.3    Asia-Pacific
3.2    Impact on Digital Respiratory Devices Adoption
         3.2.1    Short-Term Impact (2-4 Years)
         3.2.2    Mid-Term Impact (5-8 Years)
         3.2.3    Long-Term Impact (9-12 Years)
3.3    Entry Barrier and Opportunities for New Entrants

4.1    Key Developments and Strategies
         4.1.1    Agreements and Collaborations
         4.1.2    Regulatory and Legal Activities
         4.1.3    Investments, Funding, and Business Expansion
         4.1.4    Mergers and Acquisitions
         4.1.5    Awards and Recognitions
         4.1.6    Product Launches
4.2    Market Share Analysis
4.3    Industry Attractiveness
         4.3.1    Bargaining Power of Suppliers
         4.3.2    Bargaining Power of Buyer
         4.3.3    Threat of New Entrants
         4.3.4    Threat of Substitute Products
         4.3.5    Intensity of Competitive Rivalry

5.1    Opportunity Map Analysis of Smart Inhalers and Nebulizers
5.2    Smart Inhaler Value Propositions for Stakeholders
5.3    Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in Individuals
5.4    Business Models for Digital Respiratory Devices Market

6.1    Sensors and Apps
6.2    Smart Inhalers and Nebulizers

7.1    Asthma
7.2    Chronic Obstructive Pulmonary Disease (COPD)

8.1    North America
         8.1.1    U.S.
         8.1.2    Canada
8.2    Europe
         8.2.1    Germany
         8.2.2    U.K.
         8.2.3    France
         8.2.4    Rest-of-Europe
8.3    Asia-Pacific (APAC)
         8.3.1    Japan
         8.3.2    China
         8.3.3    Australia
         8.3.4    India
         8.3.5    Rest-of-Asia-Pacific (RoAPAC)
8.4    Rest-of-the-World (RoW)

9.1    3M Health Care Limited
         9.1.1    Company Overview
         9.1.2    Role of 3M Health Care Limited in the Global Digital Respiratory Devices Market
         9.1.3    Financials
                     9.1.3.1    Key Insights on the Financial Health of the Company
         9.1.4    SWOT Analysis
9.2    Adherium Limited
         9.2.1    Company Overview
         9.2.2    Role of Adherium Limited in the Global Digital Respiratory Devices Market.
         9.2.3    Financials
                     9.2.3.1    Key Insights on the Financial Health of the Company
         9.2.4    SWOT Analysis
9.3    Amiko Digital Health Limited
         9.3.1    Company Overview
         9.3.2    Role of Amiko Digital Health Limited in the Global Digital Respiratory Devices Market
         9.3.3    SWOT Analysis
9.4    AstraZeneca plc
         9.4.1    Company Overview
         9.4.2    Role of AstraZeneca plc in the Global Digital Respiratory Devices Market
         9.4.3    Financials
                     9.4.3.1    Key Insights on the Financial Health of the Company
         9.4.4    SWOT Analysis
9.5    Boehringer Ingelheim International GmbH
         9.5.1    Company overview
         9.5.2    Role of Boehringer Ingelheim International GmbH in the Global Digital Respiratory Devices Market
         9.5.3    Financials
                     9.5.3.1    Key Insights on the Financial Health of the Company
         9.5.4    SWOT Analysis
9.6    Capsule Technologies, Inc.
         9.6.1    Company Overview
         9.6.2    Role of Capsule Technologies, Inc. in the Global Digital Respiratory Devices Market.
         9.6.3    SWOT Analysis
9.7    Cognita Labs
         9.7.1    Company Overview
         9.7.2    Role of Cognita Labs in the Global Digital Respiratory Devices Market
         9.7.3    SWOT Analysis
9.8    Cohero Health
         9.8.1    Company Overview
         9.8.2    Role of Cohero Health in the Global Digital Respiratory Devices Market
         9.8.3    SWOT Analysis
9.9    Findair Sp. z. o. o
         9.9.1    Company Overview
         9.9.2    Role of Findair Sp. z. o. o in the Global Digital Respiratory Devices Market
         9.9.3    SWOT Analysis
9.10    GlaxoSmithKline plc
           9.10.1    Company overview
           9.10.2    Role of GlaxoSmithKline plc in the Global Digital Respiratory Devices Market
           9.10.3    Financials
                         9.10.3.1    Key Insights on the Financial Health of the Company
           9.10.4    SWOT Analysis
9.11    Novartis AG
           9.11.1    Company overview
           9.11.2    Role of Novartis AG in the Global Digital Respiratory Devices Market
           9.11.3    Financials
                         9.11.3.1    Key Insights on the Financial Health of the Company
           9.11.4    SWOT Analysis
9.12    Pneuma Respiratory, Inc.
           9.12.1    Company Overview
           9.12.2    Role of Pneuma Respiratory, Inc. in the Global Digital Respiratory Devices Market
           9.12.3    SWOT Analysis
9.13    Propeller Health
           9.13.1    Company Overview
           9.13.2    Role of Propeller Health in the Global Digital Respiratory Devices Market
           9.13.3    SWOT Analysis
9.14    Sensirion AG
           9.14.1    Company overview
           9.14.2    Role of Sensirion AG in the Global Digital Respiratory Devices Market
           9.14.3    Financials
                         9.14.3.1    Key Insights on the Financial Health of the Company
           9.14.4    SWOT Analysis
9.15    Teva Pharmaceuticals Industries Ltd.
           9.15.1    Company Overview
           9.15.2    Role of Teva Pharmaceuticals Industries Ltd. in the Global Digital Respiratory Devices Market
           9.15.3    Financials
                         9.15.3.1    Key Insights on the Financial Health of the Company
           9.15.4    SWOT Analysis

10.1    Product Definition
10.2    Scope of the Research Study

Table 1:    Research and Facilitation Framework
Table 2:    Global Digital Respiratory Devices Market Dynamic Impact Analysis
Table 2.1:    Impact Analysis of Global Digital Respiratory Devices Market
Table 2.2:    Incidence of Asthma in Key Countries, 2017-2019
Table 2.3:    Incidence of COPD in Key Countries, 2017-2019
Table 3.1:    Global Digital Respiratory Devices Market: Barriers to Entry
Table 5.1:    Smart Inhaler Value Propositions for Stakeholders
Table 5.2:    Different Data Revenue Streams
Table 6.1:    Global Digital Respiratory Devices Market: Smart Inhalers in Pipeline
Table 7.1:    Incidence of Asthma in Key Countries, 2017-2019
Table 7.2:    Incidence of COPD in Key Countries, 2017-2019

Figure 1:    Opportunities for Clinical Benefit
Figure 2:    Global Digital Respiratory Devices Market, 2018-2030
Figure 3:    Global Digital Respiratory Devices Market: Dominating Segment, 2019 and 2030
Figure 4:    Global Digital Respiratory Devices Market (by Product Type), 2019 and 2030
Figure 5:    Global Digital Respiratory Devices Market (by Indication), 2019 and 2030
Figure 6:    Global Digital Respiratory Devices Market (by Region), 2019 and 2030
Figure 7:    Global Digital Respiratory Devices: Strategies Incorporated to Expand Global Reach
Figure 8:    Go-To-Market Strategy
Figure 1.1:    Digital Respiratory Devices Market Workflow
Figure 1.2:    Smart Inhalers and Data Flow
Figure 1.3:    Digital Respiratory Devices Market Ecosystem
Figure 3.1:    Global Digital Respiratory Devices Market: Scenario Comparative Analysis
Figure 3.2:    COVID-19 Trend (Daily Cases), December 31, 2019-December 14, 2020
Figure 3.3:    Global Digital Respiratory Devices Market COVID-19 Impact (by Key Regions), 2019-2030
Figure 3.4:    Potential COVID-19 Recovery Scenarios
Figure 3.5:    Global Prevalence (Asthma and COPD) Historical and Forecast Growth Rates, 1990-2032
Figure 3.6:    Global Digital Respiratory Diseases Market: Opportunities for New Players
Figure 4.1:    Competitive Landscape, January 2015-March 2021
Figure 4.2:    Share of Key Developments and Strategies, January 2015-March 2021
Figure 4.3:    Agreements and Collaborations Share (by Company), January 2015 - March 2021
Figure 4.4:    Regulatory and Legal Activities Share (by Company), January 2015- March 2021
Figure 4.5:    Investments, Funding, and Business Expansions Share (by Company), January 2015-March 2021
Figure 4.6:    Mergers and Acquisitions Share (by Company), January 2015- March 2021
Figure 4.7:    Awards and Recognitions Share (by Company), January 2015-March 2021
Figure 4.8:    Product Launches Share (by Companies), January 2015-March 2021
Figure 4.9:    Global Digital Respiratory Devices Market Share Analysis, 2018 and 2019
Figure 4.10:    Porter’s Five Forces Analysis
Figure 4.11:    Bargaining Power of Suppliers: Overall Impact, 2018-2030
Figure 4.12:    Bargaining Power of Buyers: Overall Impact, 2018-2030
Figure 4.13:    Threat of New Entrant: Overall Impact, 2018-2030
Figure 4.14:    Threat of Substitute Products: Overall Impact, 2018-2030
Figure 4.15:    Intensity of Competitive Rivalry: Overall Impact, 2018-2030
Figure 5.1:    Global Digital Respiratory Devices Market: Opportunity Map Analysis
Figure 5.2:    Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in Individuals
Figure 6.1:    Global Digital Respiratory Devices Market (by Product Type)
Figure 6.2:    Global Digital Respiratory Devices Market Share (by Product Type), 2019 and 2030
Figure 6.3:    Global Digital Respiratory Devices Market (Sensors and Apps), $Million, 2018-2030
Figure 6.4:    Global Digital Respiratory Devices Market (Smart Inhalers and Nebulizers), $Million, 2018-2030
Figure 7.1:    Global Digital Respiratory Devices Market (by Indication)
Figure 7.2:    Global Digital Respiratory Devices Market Share (by Indication),  2019 and 2030
Figure 7.3:    Global Digital Respiratory Devices Market (Asthma), $Million, 2018-2030
Figure 7.4:    Global Digital Respiratory Devices Market (COPD), $Million, 2018-2030
Figure 8.1:    Global Digital Respiratory Devices Market (by Region)
Figure 8.2:    Global Digital Respiratory Devices Market (by Region), $Million, 2018-2030
Figure 8.3:    North America Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.4:    North America Digital Respiratory Devices Market (by Country), $Million, 2018-2030
Figure 8.5:    U.S. Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.6:    Canada Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.7:    Europe Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.8:    Europe Digital Respiratory Devices Market (by Country), $Million, 2018-2030
Figure 8.9:    Germany Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.10:    U.K. Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.11:    France Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.12:    Rest-of-Europe Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.13:    Asia-Pacific Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.14:    Asia-Pacific Digital Respiratory Devices Market (by Country), 2018-2030
Figure 8.15:    Japan Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.16:    China Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.17:    Australia Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.18:    India Digital Respiratory Devices Market, $Million, 2018-2030
Figure 8.19:    Rest-of-Asia-Pacific Digital Respiratory Devices Market, $Million,  2018-2030
Figure 8.20:    Rest-of-the-World Digital Respiratory Devices Market, $Million, 2018-2030
Figure 9.1:    Shares of Company Profiles
Figure 9.2:    3M Health Care Limited: Overall Product Portfolio
Figure 9.3:    3M Health Care Limited: Overall Financials, 2018-2020
Figure 9.4:    3M Health Care Limited: Revenue (by Business Segment), 2018-2020
Figure 9.5:    3M Health Care Limited: Revenue (by Region), 2018-2020
Figure 9.6:    3M Health Care Limited: R& D Expense, 2018-2020
Figure 9.7:    3M Health Care Limited: SWOT Analysis
Figure 9.8:    Adherium Limited: Overall Product Portfolio
Figure 9.9:    Adherium Limited: Overall Financials, 2018-2020
Figure 9.10:    Adherium Limited: R& D Expense, 2018-2020
Figure 9.11:    Adherium Limited: SWOT Analysis
Figure 9.12:    Amiko Digital Health Limited: Overall Product Portfolio
Figure 9.13:    Amiko Digital Health Limited: SWOT Analysis
Figure 9.14:    AstraZeneca plc: Overall Product Portfolio
Figure 9.15:    AstraZeneca plc: Overall Financials, 2018-2020
Figure 9.16:    AstraZeneca plc: Net Revenue (by Region), 2018-2020
Figure 9.17:    AstraZeneca plc: R& D Expense, 2018-2020
Figure 9.18:    AstraZeneca plc: SWOT Analysis
Figure 9.19:    Boehringer Ingelheim International GmbH: Product Offerings
Figure 9.20:    Boehringer Ingelheim International GmbH: Overall Financials, 2017-2019
Figure 9.21:    Boehringer Ingelheim International GmbH Net Revenue (by Business Segment), 2017-2019
Figure 9.22:    Boehringer Ingelheim International GmbH: Net Revenue (by Region), 2017-2019
Figure 9.23:    Boehringer Ingelheim International GmbH: R& D Expense, 2017-2019
Figure 9.24:    AstraZeneca plc: SWOT Analysis
Figure 9.25:    Capsule Technologies, Inc.: SWOT Analysis
Figure 9.26:    Cognita Labs: Overall Product Portfolio
Figure 9.27:    Cohero Health: SWOT Analysis
Figure 9.28:    Cohero Health: Overall Product Portfolio
Figure 9.29:    Cohero Health: SWOT Analysis
Figure 9.30:    Findair Sp. z. o. o: Overall Product Portfolio
Figure 9.31:    Findair Sp. z. o. o: SWOT Analysis
Figure 9.32:    GlaxoSmithKline plc: Product Offerings
Figure 9.33:    GlaxoSmithKline plc: Overall Financials, 2018-2020
Figure 9.34:    GlaxoSmithKline plc Net Revenue (by Business Segment), 2018-2020
Figure 9.35:    GlaxoSmithKline plc: Net Revenue (by Region), 2018-2020
Figure 9.36:    GlaxoSmithKline plc: R& D Expense, 2018-2020
Figure 9.37:    GlaxoSmithKline plc: SWOT Analysis
Figure 9.38:    Novartis AG: Product Offerings
Figure 9.39:    Novartis AG: Overall Financials, 2018-2020
Figure 9.40:    Novartis AG: Net Revenue (by Business Segment), 2018-2020
Figure 9.41:    Novartis AG: Net Revenue (by Region), 2018-2020
Figure 9.42:    Novartis AG: R&D Expense, 2018-2020
Figure 9.43:    Novartis AG: SWOT Analysis
Figure 9.44:    Pneuma Respiratory, Inc.: Overall Product Portfolio
Figure 9.45:    Pneuma Respiratory, Inc.: SWOT Analysis
Figure 9.46:    Propeller Health: Product Offerings for Digital Respiratory Devices Market
Figure 9.47:    Propeller Health: SWOT Analysis
Figure 9.48:    Sensirion AG: Overall Product Portfolio
Figure 9.49:    Sensirion AG: Overall Financials, 2017-2019
Figure 9.50:    Sensirion AG: Net Revenue (by Business Segment), 2017-2019
Figure 9.51:    Sensirion AG: Net Revenue (by Region), 2017-2019
Figure 9.52:    Sensirion AG: R&D Expense, 2017-2019
Figure 9.53:    Sensirion AG: SWOT Analysis
Figure 9.54:    Product Offerings for Global Digital Respiratory Devices Market
Figure 9.55:    Teva Pharmaceuticals Industries Ltd.: Net Revenue (by Business Segment), 2017-2019
Figure 9.56:    Teva Pharmaceuticals Industries Ltd.: Net Revenue (by Region), 2017-2019
Figure 9.57:    Teva Pharmaceuticals Industries Ltd.: R& D Expense, 2017-2019
Figure 9.58:    Teva Pharmaceuticals Industries Ltd.: SWOT Analysis
Figure 10.1:    Global Digital Respiratory Devices Market Segmentation
Figure 10.2:    Research Methodology
Figure 10.3:    Primary Research
Figure 10.4:    Secondary Research
Figure 10.5:    Data Triangulation
Figure 10.6:    Bottom-up Approach (Segment-wise Analysis)
Figure 10.7:    Top-down Approach (Segment-wise Analysis)
Figure 10.8:    Assumptions and Limitations
Figure 10.9:    Considered Factors for Data Prediction and Modelling